Clinical trial reportScience translational medicinePublished
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma
12 of 43 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source
- Institutions
- Perelman School of Medicine, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Science translational medicine
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Humans; Glioblastoma; Brain Neoplasms; Neoplasm Recurrence, Local; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Male; Tumor Suppressor Protein p53
- PubMed ID
- 39970230
- PubMed Central ID
- PMC11994224
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked